Accounts Receivable, after Allowance for Credit Loss, Current of Jin Medical International Ltd. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Jin Medical International Ltd. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 30 Sep 2022 to 30 Sep 2025.
Jin Medical International Ltd. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $5,807,386, a 1.8% decline year-over-year.
Source SEC data: View on sec.gov

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Jin Medical International Ltd. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$5,807,386	-$104,649	-1.8%	30 Sep 2025	20-F	10 Feb 2026	2025	FY
Q1 2025	$4,238,724	+$382,195	+9.9%	31 Mar 2025	6-K	20 Aug 2025	2025	Q2
Q3 2024	$5,912,035	+$2,628,769	+80%	30 Sep 2024	20-F	10 Feb 2026	2025	FY
Q1 2024	$3,856,529	+$3,564,646	+1221%	31 Mar 2024	6-K	26 Jul 2024	2024	Q2
Q3 2023	$3,283,266	-$547,610	-14%	30 Sep 2023	20-F	24 Jan 2025	2024	FY
Q1 2023	$291,883			31 Mar 2023	6-K	23 Aug 2023	2023	Q2
Q3 2022	$3,830,876			30 Sep 2022	20-F	26 Apr 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.